Jeena Sikho Lifecare Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹235 Cr +23.9% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
JS

Jeena Sikho Lifecare Ltd

Q3 FY26Leisure Services

Jeena Sikho Lifecare Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹222Cr
+91.4% YoY
+16.8% QoQ
Net profit
₹67Cr
+415.4% YoY
+13.6% QoQ
Margin
45%
+19 pp YoY
−3 pp QoQ

Jeena Sikho Lifecare Ltd Q3 FY26 key numbers

Revenue
OTC product portfolio expected to expand to 16 products by end of 2026, with monthly sales goals of INR10 crores for initial products and INR500 crores OTC revenue in 2 years.

As stated in Jeena Sikho Lifecare Ltd's Q3 FY26 earnings call transcript · published 1 Jun 2026. Reported figures, not investment advice.

Price₹505
Market cap₹7.2K Cr
P/E32.4

The short version

Target to reach INR1,000 crores profit from sales over the next 3-4 years, representing a 4x to 5x increase from current levels (Page 17). Current profit expected to be approximately INR 225 crores for the year.

From Jeena Sikho Lifecare Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Target to reach INR1,000 crores profit from sales over the next 3-4 years, representing a 4x to 5x increase from current levels (Page 17).
  • Focus on increasing operational beds from current ~2,200 to 7,000–10,000 beds within 3-5 years, targeting 70%-80% occupancy (Pages 16-17).
  • OTC product portfolio expected to expand to 16 products by end of 2026, with monthly sales goals of INR10 crores for initial products and INR500 crores OTC revenue in 2 years (Pages 4, 17-18).

2 more points from Jeena Sikho Lifecare Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Jeena Sikho Lifecare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current capex per bed is INR 3 to 4 lakh; setting up 100 beds costs approximately INR 3 to 4 crores.
  • Plan to increase total beds to 7,000 to 10,000 over the next 3 to 5 years (currently around 2,800 beds, 2,290 operational).
  • Intention to focus on internal growth within Ayurvedic products, services, international business, and diagnostics.
  • No plans to expand beyond Ayurveda-related fields; aim to become market leader in Ayurveda in India, Asia, and then globally.
  • Exploring high-level acquisitions or tie-ups to accelerate growth, but such discussions are ongoing and subject to valuation negotiations.
  • Launching multiple new Ayurvedic products this year (targeting 16 products by December 2026) to drive revenue growth.

2 more points from Jeena Sikho Lifecare Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Leisure Services

Ranked on what management guided this quarter

Guidance-ranked
1Kamat Hotels
Rev 2Mar 1
2Grand Continent
Rev 2Mar 1
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Jeena Sikho Lifecare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some related points can be inferred: - The company has recently formed a partnership with Entero, a pharmacy distributor with a network of 1.25 lakh distributors covering around 10% of India's 9 lakh medical stores, expected to boost OTC product reach. - Plans to launch multiple OTC Ayurvedic products this year (targeting 16 products by December 2026), indicating a growing pipeline of products to be marketed and distributed. - The company is focused on expanding hospital beds to 7,000-10,000 over 3-5 years and increasing occupancy to 70%-80%, suggesting ongoing capacity-building orders.

Jeena Sikho Lifecare Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Jeena Sikho Lifecare Ltd Q3 FY26 results — key figures

Jeena Sikho Lifecare Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue222116+91.4%190+16.8%
Operating profit (EBITDA)10130+236.7%92+9.8%
Operating margin45%26%+19 pp48%-3 pp
Profit before tax8918+394.4%79+12.7%
Net profit (PAT)6713+415.4%59+13.6%
EPS (₹)5.371.06+406.6%4.73+13.5%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹235 Cr, net profit ₹36 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Leisure Services this season

  • Sinclairs Hotels (Q3 FY26)

    1780.49 lakh, up 23.40% year-on-year. Key investor presentation takeaways from Sinclairs Hotels's Q3 FY26 investor presentation — and how it ranks against secto

  • ITC Hotels (Q3 FY26)

    Q3 FY26 Revenue from Operations (Standalone): ₹1,052 Cr, up 12% YoY (Page 45) . Key concall takeaways from ITC Hotels Ltd's Q3 FY26 earnings call — and how it…

  • EIH Associated Hotels (Q3 FY26)

    Q3 FY26 Revenue from Operations: Rs 129.5 crores, down from Rs 133.0 crores in Q3 FY25 (approx. Key concall takeaways from EIH Associated Hotels Ltd's Q3 FY26…

  • Easy Trip Planners (Q3 FY26)

    Q3 FY26 Revenue from Operations: INR 151.7 Cr (Page 5) . Key concall takeaways from Easy Trip Planners Ltd's Q3 FY26 earnings call — and how it ranks against…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Jeena Sikho Lifecare Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Jeena Sikho Lifecare Ltd Q3 FY26 results?

Target to reach INR1,000 crores profit from sales over the next 3-4 years, representing a 4x to 5x increase from current levels (Page 17). Current profit expected to be approximately INR 225 crores for the year.

What is Jeena Sikho Lifecare Ltd share price analysis?

Jeena Sikho Lifecare Ltd currently shows a neutral. The stock trades at a P/E of 32.4 with a market cap of ₹7,200 Cr. Investors should review the full earnings analysis for detailed insights.

Is Jeena Sikho Lifecare Ltd planning capital expenditure?

Current capex per bed is INR 3 to 4 lakh; setting up 100 beds costs approximately INR 3 to 4 crores.

Keep Jeena Sikho Lifecare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.